We were very pleased to host a visit of the National Research Infrastructure Advisory group and a delegation of government officials from the Department of Education (DoE) on the 28th of March to several NCRIS facilities based at the Australian National University, including Phenomics Australia, Bioplatforms Australia (BPA), Therapeutic Innovation Australia (TIA), and the Australian Plant Phenomics Facility (APPF).
Australian synthetic biology research delivers solutions to important societal challenges including protection of public health, environmental protection, agricultural productivity, climate change mitigation and adaptation, and environmentally sustainable manufacturing.
This visit was part of a familiarisation tour to learn some examples of inter and intra National Collaborative Research Infrastructure Strategy (NCRIS) capability investments and benefits relevant to synthetic biology.
The expert staff from Phenomics Australia, TIA, and BPA’s associated facilities at the ANU Centre for Therapeutic Discovery (ACTD) and the Biomolecular Resource Facility (BRF) at the JCSMR also got to talk to the visitors about their careers and how they are using advanced genetics and precision medicine technologies to track record medical innovations supporting their translation into real-world impact.
Establishing an Advisory Group was a key recommendation of the 2021 NRI Roadmap.
The Advisory Group will advise on priorities, trends, and investment opportunities to ensure that researchers have access to cutting-edge NRI. The Group’s role is critical in supporting a modern NRI ecosystem that is flexible, relevant, and responsive to emerging research needs and challenges.
We look forward to their continuing interest in Phenomics Australia and NCRIS and hope to see them back soon.
